{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:42:08Z","timestamp":1773297728775,"version":"3.50.1"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T00:00:00Z","timestamp":1590105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["T32-DK007740"],"award-info":[{"award-number":["T32-DK007740"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Opioid use is associated with excess mortality in patients with inflammatory bowel disease (IBD). Recent data have highlighted that inpatient opioid exposure is associated with postdischarge opioid use in this population. It is unknown if preadmission use of cannabis, which is commonly used for symptom relief among patients with IBD, increases the risk for inpatient opioid exposure when patients lack access to cannabis for symptom management. We sought to determine the association between preadmission cannabis use and inpatient opioid exposure while adjusting for relevant confounders.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We performed a retrospective cohort study of adult patients hospitalized for IBD within a large academic health system from March 1, 2017, to April 10, 2018. Opioid exposure was calculated by converting the sum of administered opioid doses to intravenous morphine milligram equivalents and dividing by length of stay. We used multivariable linear regression to assess the association between cannabis use and inpatient opioid exposure while adjusting for confounders including IBD severity and preadmission opioid use.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Our study included 423 IBD patients. Linear regression analysis showed a significant positive correlation between inpatient opioid exposure (intravenous morphine milligram equivalents divided by length of stay) and preadmission cannabis use (coefficient = 12.1; 95% confidence interval [CI], 2.6-21.5). Other significantly associated variables were first patient-reported pain score (coefficient = 1.3; 95% CI, 0.6-2.0) and preadmission opioid use (coefficient = 22.3; 95% CI, 17.0-27.6).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Cannabis use is positively correlated with inpatient opioid exposure after controlling for confounders. A personalized pain management approach should be considered to limit inpatient and possibly future opioid exposure among hospitalized patients with IBD who use cannabis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ibd\/izaa104","type":"journal-article","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T04:20:03Z","timestamp":1590121203000},"page":"500-506","source":"Crossref","is-referenced-by-count":8,"title":["Preadmission Cannabis Use Is Positively Correlated With Inpatient Opioid Dose Exposure in Hospitalized Patients With Inflammatory Bowel Diseases"],"prefix":"10.1093","volume":"27","author":[{"given":"Rahul S","family":"Dalal","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School , Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonali","family":"Palchaudhuri","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, University of Pennsylvania Perelman School of Medicine , Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher K","family":"Snider","sequence":"additional","affiliation":[{"name":"Center for Health Care Innovation, University of Pennsylvania , Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D","family":"Lewis","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, University of Pennsylvania Perelman School of Medicine , Philadelphia, Pennsylvania, USA"},{"name":"Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia , Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivan J","family":"Mehta","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, University of Pennsylvania Perelman School of Medicine , Philadelphia, Pennsylvania, USA"},{"name":"Center for Health Care Innovation, University of Pennsylvania , Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary R","family":"Lichtenstein","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, University of Pennsylvania Perelman School of Medicine , Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,5,22]]},"reference":[{"key":"2022092603083532800_CIT0001","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/ibd.21806","article-title":"Narcotic use for inflammatory bowel disease and risk factors during hospitalization","volume":"18","author":"Long","year":"2012","journal-title":"Inflamm Bowel Dis."},{"key":"2022092603083532800_CIT0002","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/ajg.2012.218","article-title":"Serious infection and mortality in patients with Crohn\u2019s disease: more than 5 years of follow-up in the TREAT registry","volume":"107","author":"Lichtenstein","year":"2012","journal-title":"Am J Gastroenterol."},{"key":"2022092603083532800_CIT0003","article-title":"Exposure to intravenous opioids is associated with future exposure to opioids in hospitalized patients with inflammatory bowel diseases","author":"Dalal","year":"2019","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2022092603083532800_CIT0004","doi-asserted-by":"crossref","DOI":"10.14309\/01.ajg.0000592092.86224.cd","article-title":"A multimodal intervention reduces intravenous opioid exposure among hospitalized patients with inflammatory bowel disease.","volume-title":"American College of Gastroenterology Annual Scientific Meeting","author":"Dalal","year":"2019;"},{"key":"2022092603083532800_CIT0005","volume-title":"2015"},{"key":"2022092603083532800_CIT0006","volume-title":"Distribution of Medical Marijuana Dispensaries from 2007 to 2014, Los Angeles, CA","author":"UCLA Medical Marijuana Research"},{"key":"2022092603083532800_CIT0007","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/ajg.2014.245","article-title":"Medical marijuana for digestive disorders: high time to prescribe?","volume":"110","author":"Gerich","year":"2015","journal-title":"Am J Gastroenterol."},{"key":"2022092603083532800_CIT0008","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13722-015-0032-7","article-title":"Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders","volume":"10","author":"Belendiuk","year":"2015","journal-title":"Addict Sci Clin Pract."},{"key":"2022092603083532800_CIT0009","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1016\/j.cgh.2019.01.018","article-title":"Effects of medical cannabis on use of opioids and hospital visits by patients with painful chronic pancreatitis","volume":"17","author":"Barlowe","year":"2019","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2022092603083532800_CIT0010","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bcp.2008.06.022","article-title":"The profile of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT)","volume":"76","author":"Kaplan","year":"2008","journal-title":"Biochem Pharmacol."},{"key":"2022092603083532800_CIT0011","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/npp.2009.184","article-title":"Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology","volume":"35","author":"Bhattacharyya","year":"2010","journal-title":"Neuropsychopharmacology."},{"key":"2022092603083532800_CIT0012","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1126\/science.1115740","article-title":"Identification and functional characterization of brainstem cannabinoid CB2 receptors","volume":"310","author":"Van Sickle","year":"2005","journal-title":"Science."},{"key":"2022092603083532800_CIT0013","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/01.MIB.0000440982.79036.d6","article-title":"Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn\u2019s disease","volume":"20","author":"Storr","year":"2014","journal-title":"Inflamm Bowel Dis."},{"key":"2022092603083532800_CIT0014","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/MEG.0b013e328349bb4c","article-title":"Cannabis use amongst patients with inflammatory bowel disease","volume":"23","author":"Lal","year":"2011","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"2022092603083532800_CIT0015","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1097\/01.MIB.0000435851.94391.37","article-title":"Marijuana use patterns among patients with inflammatory bowel disease","volume":"19","author":"Ravikoff Allegretti","year":"2013","journal-title":"Inflamm Bowel Dis."},{"key":"2022092603083532800_CIT0016","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.drugalcdep.2015.08.035","article-title":"Patterns of cannabis use in patients with inflammatory bowel disease: a population based analysis","volume":"156","author":"Weiss","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"2022092603083532800_CIT0017"},{"key":"2022092603083532800_CIT0018","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/ibd\/izz089","article-title":"Hospitalization outcomes for inflammatory bowel disease in teaching vs nonteaching hospitals","volume":"25","author":"Dalal","year":"2019","journal-title":"Inflamm Bowel Dis."},{"key":"2022092603083532800_CIT0019","first-page":"134","article-title":"Tofacitinib is not a biologic","volume":"30","author":"Marren","year":"2017","journal-title":"Ann Gastroenterol."},{"key":"2022092603083532800_CIT0020","volume-title":". Narcotic Equivalence Converter","author":"MedCalc","year":"2019"},{"key":"2022092603083532800_CIT0021","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.cgh.2017.10.022","article-title":"Increasing prescription of opiates and mortality in patients with inflammatory bowel diseases in England","volume":"16","author":"Burr","year":"2018","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2022092603083532800_CIT0022","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0304-3959(95)00180-8","article-title":"Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain","volume":"64","author":"Donner","year":"1996","journal-title":"Pain."},{"key":"2022092603083532800_CIT0023","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/ibd\/izz272","article-title":"Cannabis use in persons with inflammatory bowel disease and vulnerability to substance misuse","volume":"26","author":"Hansen","year":"2020","journal-title":"Inflamm Bowel Dis."},{"key":"2022092603083532800_CIT0024","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.drugalcdep.2015.01.004","article-title":"Associations between cigarette smoking and cannabis dependence: a longitudinal study of young cannabis users in the United Kingdom","volume":"148","author":"Hindocha","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"2022092603083532800_CIT0026","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1111\/j.1572-0241.2008.02054.x","article-title":"Does it matter where you are hospitalized for inflammatory bowel disease? A nationwide analysis of hospital volume","volume":"103","author":"Ananthakrishnan","year":"2008","journal-title":"Am J Gastroenterol."},{"key":"2022092603083532800_CIT0027","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1046\/j.1440-1746.2001.02468.x","article-title":"Chronic narcotic use in inflammatory bowel disease patients: prevalence and clinical characteristics","volume":"16","author":"Edwards","year":"2001","journal-title":"J Gastroenterol Hepatol."},{"key":"2022092603083532800_CIT0028","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1111\/j.1572-0241.2005.00256.x","article-title":"Narcotic use in patients with Crohn\u2019s disease","volume":"100","author":"Cross","year":"2005","journal-title":"Am J Gastroenterol."},{"key":"2022092603083532800_CIT0029","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ibd.20847","article-title":"Clinical features and outcome of patients with inflammatory bowel disease who use narcotics: a case-control study","volume":"15","author":"Hanson","year":"2009","journal-title":"Inflamm Bowel Dis."},{"key":"2022092603083532800_CIT0030","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.jpain.2017.06.010","article-title":"Factors influencing long-term opioid use among opioid naive patients: an examination of initial prescription characteristics and pain etiologies","volume":"18","author":"Shah","year":"2017","journal-title":"J Pain."},{"key":"2022092603083532800_CIT0031","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1097\/MCG.0b013e31821fbd82","article-title":"Understanding and treating abdominal pain and spasms in organic gastrointestinal diseases: inflammatory bowel disease and biliary diseases","volume":"45","author":"Makharia","year":"2011","journal-title":"J Clin Gastroenterol."},{"key":"2022092603083532800_CIT0032","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cgh.2005.12.002","article-title":"Safety of celecoxib in patients with ulcerative colitis in remission: a randomized, placebo-controlled, pilot study","volume":"4","author":"Sandborn","year":"2006","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2022092603083532800_CIT0033","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cgh.2013.04.034","article-title":"Cannabis induces a clinical response in patients with Crohn\u2019s disease: a prospective placebo-controlled study","volume":"11","author":"Naftali","year":"2013","journal-title":"Clin Gastroenterol Hepatol."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/27\/4\/500\/46041179\/izaa104.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/27\/4\/500\/46041179\/izaa104.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T03:10:31Z","timestamp":1664161831000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/27\/4\/500\/5841912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,22]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,5,22]]},"published-print":{"date-parts":[[2021,3,15]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izaa104","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4,1]]},"published":{"date-parts":[[2020,5,22]]}}}